In addition to the development of new excipients, Fuji Chemical has actively challenged the development of DDS technology based on SD technology. We are engaged in the development of original technologies, such as controlled release and enhancement of solubility of poorly soluble drugs; further, we aim to develop a patient-friendly approach by supplying drugs to patients for improving their drug compliance.